RNU6-1218P

Across TCGA pan-cancer cohorts, RNU6-1218P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-1218P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-1218P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1218P expression acts as an unfavorable survival marker.

ESCA, BLCA, and THCA are the cancer types where RNU6-1218P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.395	0.710	.001	63	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
THCA	OS	Tertile	All	0.594	0.942	<.001	36	view →
BRCA	OS	Tertile	II,III,IV	0.668	0.913	.019	18	view →
SKCM	DFS	Tertile	All	0.023	0.738	<.001	18	view →
UCEC	OS	Tertile	II,III,IV	0.467	0.770	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-1218P–ESCA (OS)

Open the ESCA breakdown →